Avery Dennison advances RFID adoption with AD Fusion

About Avery Dennison

Avery Dennison Corporation is a worldwide materials science and digital identification solutions organization. This company is Making PossibleTM products and services that supports to advance the industries serve, offering branding and data services that optimize labor and supply chain effectiveness, lower waste and avoid loss, advance sustainability, circularity and transparency, and advance connecting brands and customers. This organization designs and develops labeling and functional materials, radio-frequency identification (RFID) inlays and tags, and software applications that connect the physical and digital, providing solutions that improve branded packaging and carry or display data that enhance the consumer experience. Serving industries globally involving home and targeted care, apparel, general retail, e-commerce, logistics, food and grocery, healthcare, and automotive employ around 35,000 employees in more than 50 countries.

A recent report by Towards Healthcare highlights that the European RFID in pharmaceuticals market is growing, as RFID readers are becoming more efficient and significantly life-saving when monitoring therapeutic quality and product flow. Strict regulatory frameworks lead to the amplified deployment of RFID readers in supply chain solutions to ensure adherence to accreditation conditions set by the administration. With next-generation RFID tags and readers, drug producers and wholesalers are implementing an effective labeling solution to lower healthcare errors and enhance the safety of targeted healthcare products. There are major advantages for the pharmaceutical sector to incorporate RFID technology in its supply chain. It is a challenging task that requires more data and organization than is usually the case. RFID allows end-to-end shipment visibility, rapid receiving and dispatch, and lowers losses, making logistics more reliable and transparent.